Zai Lab
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zai Lab and other ETFs, options, and stocks.About ZLAB
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra.
CEOYing Du
CEOYing Du
Employees1,784
Employees1,784
HeadquartersShanghai, Shanghai
HeadquartersShanghai, Shanghai
Founded2014
Founded2014
Employees1,784
Employees1,784
ZLAB Key Statistics
Market cap2.12B
Market cap2.12B
Price-Earnings ratio-11.83
Price-Earnings ratio-11.83
Dividend yield—
Dividend yield—
Average volume620.35K
Average volume620.35K
High today$19.38
High today$19.38
Low today$18.72
Low today$18.72
Open price$18.98
Open price$18.98
Volume228.75K
Volume228.75K
52 Week high$44.34
52 Week high$44.34
52 Week low$15.96
52 Week low$15.96
ZLAB News
TipRanks 6h
Zai Lab price target lowered to $32 from $39 at JPMorganJPMorgan analyst Anupam Rama lowered the firm’s price target on Zai Lab (ZLAB) to $32 from $39 and keeps an Overweight rating on the shares. The firm updated mo...
TipRanks 5d
Zai Lab Advances DLLEVATE Trial In Relapsed Small Cell Lung CancerZai Lab Ltd (ZLAB) announced an update on their ongoing clinical study. Zai Lab Ltd. is advancing a late stage study called DLLEVATE that compares its drug ZL-...
Analyst ratings
87%
of 15 ratingsBuy
86.7%
Hold
13.3%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.